Results: 26
Clinical experience and outcomes in patients with pineal parenchymal tumor of intermediate differentiation (PPTID): a single-institution analysis.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 527, doi. 10.1007/s11060-022-04174-6
- By:
- Publication type:
- Article
Patient satisfaction and cost savings analysis of the telemedicine program within a neuro-oncology department.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 517, doi. 10.1007/s11060-022-04173-7
- By:
- Publication type:
- Article
Radiotherapy for meningiomas.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 505, doi. 10.1007/s11060-022-04171-9
- By:
- Publication type:
- Article
Integration of molecular pathology with histopathology to accurately evaluate the biological behaviour of WHO grade 2 meningiomas and patient prognosis.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 497, doi. 10.1007/s11060-022-04170-w
- By:
- Publication type:
- Article
Prognostic implication of size on outcomes of pituitary macroadenoma: a comparative analysis of giant adenoma with non-giant macroadenoma.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 491, doi. 10.1007/s11060-022-04168-4
- By:
- Publication type:
- Article
Matched case–control analysis of outcomes following surgical resection of incidental meningioma.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 481, doi. 10.1007/s11060-022-04167-5
- By:
- Publication type:
- Article
Ventricular entry during surgical resection is associated with intracranial leptomeningeal dissemination in glioblastoma patients.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 473, doi. 10.1007/s11060-022-04166-6
- By:
- Publication type:
- Article
Assessment of radiographic and prognostic characteristics of programmed death-ligand 1 expression in high-grade gliomas.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 463, doi. 10.1007/s11060-022-04165-7
- By:
- Publication type:
- Article
Comparison of surgery with or without adjuvant radiotherapy in treating central neurocytoma: a single-center retrospective real-world study.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 455, doi. 10.1007/s11060-022-04164-8
- By:
- Publication type:
- Article
What surgical approach for left-sided eloquent glioblastoma: biopsy, resection under general anesthesia or awake craniotomy?
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 445, doi. 10.1007/s11060-022-04163-9
- By:
- Publication type:
- Article
Standard or extended STUPP? Optimal duration of temozolomide for patients with high-grade gliomas: a retrospective analysis.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 433, doi. 10.1007/s11060-022-04162-w
- By:
- Publication type:
- Article
Brainstem tumors may increase the impairment of behavioral emotional cognition in children.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 423, doi. 10.1007/s11060-022-04161-x
- By:
- Publication type:
- Article
Improving quality of life post-tumor craniotomy using personalized, parcel-guided TMS: safety and proof of concept.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 413, doi. 10.1007/s11060-022-04160-y
- By:
- Publication type:
- Article
Seizures in patients with IDH-mutated lower grade gliomas.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 403, doi. 10.1007/s11060-022-04158-6
- By:
- Publication type:
- Article
Observational real-life study on regorafenib in recurrent glioblastoma: does dose reduction reduce toxicity while maintaining the efficacy?
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 389, doi. 10.1007/s11060-022-04155-9
- By:
- Publication type:
- Article
NMDA receptor signaling induces the chemoresistance of temozolomide via upregulation of MGMT expression in glioblastoma cells.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 375, doi. 10.1007/s11060-022-04154-w
- By:
- Publication type:
- Article
Moderately hypofractionated versus conventionally fractionated radiation therapy with temozolomide for young and fit patients with glioblastoma: an institutional experience and meta-analysis of literature.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 361, doi. 10.1007/s11060-022-04151-z
- By:
- Publication type:
- Article
Effect of cabergoline on tumor remnant after surgery in nonfunctioning pituitary adenoma.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 351, doi. 10.1007/s11060-022-04149-7
- By:
- Publication type:
- Article
Concurrent chemoradiation and Tumor Treating Fields (TTFields, 200 kHz) for patients with newly diagnosed glioblastoma: patterns of progression in a single institution pilot study.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 345, doi. 10.1007/s11060-022-04146-w
- By:
- Publication type:
- Article
Letter to the Editor.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 341, doi. 10.1007/s11060-022-04143-z
- By:
- Publication type:
- Article
Is intraoperative MRI use in malignant brain tumor surgery a health care burden? A matched analysis of MarketScan Database.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 331, doi. 10.1007/s11060-022-04142-0
- By:
- Publication type:
- Article
Does preoperative gamma knife treatment affect the result of microresection of vestibular schwannoma?
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 321, doi. 10.1007/s11060-022-04140-2
- By:
- Publication type:
- Article
Diffusion tensor imaging changes in patients with glioma-associated seizures.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 311, doi. 10.1007/s11060-022-04139-9
- By:
- Publication type:
- Article
CRISPR/Cas9-mediated abrogation of CD95L/CD95 signaling-induced glioma cell growth and immunosuppression increases survival in murine glioma models.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 299, doi. 10.1007/s11060-022-04137-x
- By:
- Publication type:
- Article
Preoperative frailty measured by risk analysis index predicts complications and poor discharge outcomes after Brain Tumor Resection in a large multi-center analysis.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 285, doi. 10.1007/s11060-022-04135-z
- By:
- Publication type:
- Article
High end-of-life incidence of seizures and status epilepticus in patients with primary and secondary brain tumors.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 160, n. 2, p. 277, doi. 10.1007/s11060-022-04133-1
- By:
- Publication type:
- Article